Strengthening Patient and Healthcare Worker Safety Across India
BD (Becton, Dickinson and Company), a global leader in medical technology, in collaboration with Joint Commission International (JCI), has expanded its flagship PRIME (Preventing Risks of Infections and Medication Errors) program in IV therapy to six more hospitals across India. These hospitals include:
- Apollo Hospital, Greams Road, Chennai
- BLK-Max Super Speciality Hospital, Delhi
- Amala Institute of Medical Sciences, Thrissur
- Apollo Hospital, Jubilee Hills, Hyderabad
- HCG Aastha Cancer Centre, Ahmedabad
- Apollo Hospital, Visakhapatnam
A Benchmark Program Since 2019
As per the press release, launched in 2019, the PRIME program has now been implemented in 30 hospitals across India. Over a six-month period, each hospital engages in a comprehensive, goal-oriented approach to patient safety, including:
- Goal setting and regular progress reviews
- Tele-consultations with subject-matter experts
- Scientific updates through webinars
Hospitals that successfully complete the program receive the PRIME certification, representing the Gold Standard in safety practices for IV therapy.
Expert Endorsement from JCI
Highlighting the significance of the program, the Principal Consultant for Medication Management and Safety at JCI stated:
“JCI is proud to contribute to patient safety through the ongoing mentoring and development of the PRIME program. It uniquely addresses core skills related to medication preparation, administration, and vascular access management.”
BD’s Continued Commitment to Safer Healthcare
Atul Grover, Managing Director of BD India/South Asia, emphasized BD’s mission:
“At BD, we are committed to advancing the world of health by introducing safe, innovative technologies and continuous training for healthcare professionals. The PRIME program helps prevent infections and medication errors, which are critical to enhancing both patient care and healthcare worker safety.”
Resilience Through the Pandemic
Despite the challenges posed by the COVID-19 pandemic, BD and JCI maintained strong support for healthcare professionals by delivering the PRIME program both virtually and in-person. Their dedication has resulted in increased engagement, improved safety practices, and measurable enhancements in patient outcomes.